Stock Track | Hims & Hers Health Soars 5.15% as Morgan Stanley Initiates Coverage with Overweight Rating

Stock Track2024-12-17

Hims & Hers Health Inc. (HIMS) stock surged 5.15% in Tuesday's pre-market session, following Morgan Stanley's initiation of coverage on the telemedicine company with an Overweight rating.

Morgan Stanley analysts see significant growth potential for the company, which provides direct-to-consumer healthcare services, including prescriptions and over-the-counter products. The brokerage firm set a price target of $26.77 on Hims & Hers Health, implying an upside of over 50% from the stock's current levels.

The bullish initiation from Morgan Stanley has fueled investor optimism about Hims & Hers Health's prospects, driving the stock's strong pre-market rally. The company's innovative telehealth model and growing product portfolio have positioned it well to capitalize on the burgeoning digital healthcare market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment